HEALTHY STUDY PARTICIPANTS
Clinical trials for HEALTHY STUDY PARTICIPANTS explained in plain language.
Never miss a new study
Get alerted when new HEALTHY STUDY PARTICIPANTS trials appear
Sign up with your email to follow new studies for HEALTHY STUDY PARTICIPANTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Parkinson's drug shows promise in early safety trial
Symptom relief CompletedThis study tested a new drug called UCB0022 in 100 healthy volunteers and people with Parkinson's disease. The main goal was to check if the drug is safe and how the body processes it. This is an early-stage trial, so it does not prove the drug works for Parkinson's symptoms yet.
Matched conditions: HEALTHY STUDY PARTICIPANTS
Phase: PHASE1 • Sponsor: UCB Biopharma SRL • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New drug UCB0022 tested for safety in healthy people
Knowledge-focused CompletedThis early-stage trial tested the safety and tolerability of a new drug called UCB0022 (glovadalen) in 32 healthy adults from Caucasian, Japanese, and Chinese backgrounds. Participants received either the drug or a placebo in increasing doses. The study is complete and focused on…
Matched conditions: HEALTHY STUDY PARTICIPANTS
Phase: PHASE1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
Healthy volunteers help uncover drug interactions
Knowledge-focused CompletedThis study looked at how a medicine called ZX008 changes the way the body processes three other drugs (midazolam, bupropion, and metformin). Twenty-two healthy adults aged 18 to 55 took part. The goal was to measure drug levels in the blood, not to treat any disease.
Matched conditions: HEALTHY STUDY PARTICIPANTS
Phase: PHASE1 • Sponsor: UCB BIOSCIENCES, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC
-
Healthy volunteers help test how a new drug is absorbed
Knowledge-focused CompletedThis early-stage study looked at how a new drug, UCB0599, is absorbed in healthy adults. It also checked if stomach acid levels affect absorption and tested safety in Japanese and Chinese participants. The goal was to gather information, not to treat any disease.
Matched conditions: HEALTHY STUDY PARTICIPANTS
Phase: PHASE1 • Sponsor: UCB Biopharma SRL • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC